Africa: Hummingbird Bioscience Publishes Preclinical Data Demonstrating Efficacy of Hmbd-001 in Her3 Driven Cancers

[PR Newswire] Singapore -HER3 activation is implicated in tumor progression and in acquired resistance to EGFR and HER2 therapies

Source: AllAfrica News: Health and Medicine - January 8, 2020 Category: African Health Source Type: news